Isocitrate Dehydrogenase Inhibitors in Cancer Chemotherapy

Isocitrate Dehydrogenase Inhibitors in Cancer Chemotherapy presents an in-depth and up-to-date compilation of research on isocitrate dehydrogenase as drug target to be used as a sensitizing agent in chemotherapy. The book brings a combination of medicinal, biological and chemical points-of-view to fully cover the subject. It discusses topics such as IDH place in cellular metabolism, mutant IDH as drug target, mono- and poli-therapies based on IDH1/2 inhibitors, and IDH1/2 inhibitors in leukemia, gliomas and other brain tumors, and potential importance in gastrointestinal cancers. Additionally, it discusses isocitrate dehydrogenases as target for theranostics, therapeutic strategies and future perspectives.

This is a valuable resource for cancer researchers, oncologists and members of the biomedical field who are interested to learn more about IDH inhibitors and their potential as sensitizing agents for chemotherapy.

• Presents comprehensive and up-to-date review of current trends in design IDH inhibitors and their use as adjuvant therapy
• Contains summarized tables and schematic diagrams in each chapter to give a clear overview of the recent findings in a didactic manner
• Brings not only relevant information of current research but also new ideas and suggestions for further investigations to help advance the field